Posted by Michael Wonder on 11 Aug 2021
Withdrawals from the pharmaceutical benefits on 1 September 2021
10 August 2021 - Faslodex is among the medicines being withdrawn from the drug benefits on 1 September 2021.
Faslodex 250 mg/5 mL solution in pre-filled syringes for injection is withdrawn from the benefits at the request of AstraZeneca.
Generic and parallel-distributed packaging remains within the benefits.
